Skip to main content
OpenTrials
Completed

NCT Number: NCT07184268

Clinical Efficacy of NST With Adjunctive Local Delivery of Ozonated Olive Versus Curcumin Gel in Stage II Grade B Periodontitis.

The aim of this clinical trial is to evaluate the effectiveness of local delivery ozonated olive gel versus curcumin gel as adjunct to scaling and root planing in the treatment of stage II grade B periodontitis in on both males and females in the age group between 18 and 50 years. outcome measures are Clinical attachment level (CAL), plaque index (PI), gingival index (GI).

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Modern University for technology and information

Cairo, Egypt

About this study

Periodontitis is an advanced periodontal disease with a distinctive clinical signs and symptoms as rapid attachment loss and bone destruction

The primary treatment approach for periodontitis is mechanical plaque removal through debridement, particularly scaling and root planing (SRP) using hand or ultrasonic instruments.

curcumin gel is an adjunct to non-surgical periodontal therapy is a highly potent local antioxidant and anti-inflammatory agent. While ozone has a potent antimicrobial and anti-inflammatory effects it also can be incorporated into a lipid carrier such as olive oil. Ozone's stability and ease of application are markedly enhanced. Ozonized olive oil can be formulated into a gel with ideal rheological properties for injection into periodontal pockets.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients diagnosed with stage II periodontitis defined by having interdental CAL 3-4 mm and presence of pocket depth (PD) ≤ 5 mm, and grade B periodontitis characterized by a moderate rate of disease progression.
  • Patients agree to a 3-month follow-up period and provide an informed consent.

Exclusion criteria

  • Presence of prosthetic crowns, overhanging restorations and orthodontic treatment.
  • Teeth with both endo-perio lesions.
  • Antibiotics therapy that has an impact on the clinical signs and symptoms of periodontitis in the previous 3 months.
  • Anti-inflammatory drugs in the previous 1 month.
  • History of systemic disease, allergy, cardiovascular diseases, diabetes mellitus, hypertension, bleeding disorders, hyperparathyroidism, and compromised medical conditions, pregnant and lactating females.

Treatment and study plan

full mouth non-surgical scaling

Procedure

All patients will receive a full mouth scaling using ultrasonic scalers and hand instrumentation

Primary outcomes

  1. Clinical attachment level

    Time frame: 3 months

    measured from the cementoenamel junction (CEJ) to the bottom of pocket.

Secondary outcomes

  1. Gingival Index

    Time frame: 3 months

    Index scores will be recorded showing gingival bleeding and inflammation

  2. Plaque index

    Time frame: 3 months

    be used to evaluate plaque accumulation

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Collaborators

  • MTI University

Registry information

Official study title

Clinical Efficacy of Non-surgical Therapy With Adjunctive Local Delivery of Ozonated Olive Oil Gel Versus Curcumin Gel in Stage II Grade B Periodontitis Randomized Controlled Clinical Trial.

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Sep 19, 2025
Registry last updated
Jul 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.